| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 08/14/2008 | WO2008049855A3 7-azaindole derivatives as c-met kinase inhibitors |
| 08/14/2008 | WO2007081890A8 Production of dolasetron |
| 08/14/2008 | WO2007072158A8 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 08/14/2008 | US20080194822 Heating 4-chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline with ammonia in a polar aprotic solvent to produce imiquimod; purification; industrial scale; dechlorination; precipitation, crystallization, slurrying, washing in a suitable solvent, filtration through a packed-bed column, dissolution in solvent |
| 08/14/2008 | US20080194803 Using silent information regulator 2 (Sir2) protein activators as therapeutic agents in treatment and prevention of nervous system, eating, sleep and psychological disorders |
| 08/14/2008 | US20080194617 Fused ring compound |
| 08/14/2008 | US20080194616 Analgesics; antidepressants; cardiovascular disorders; respiratory system disorders; antiinflammatory agents; inflammatory bowel disorders; headaches |
| 08/14/2008 | US20080194615 Substituted Tetrahydroquinolines |
| 08/14/2008 | US20080194607 Modulation of pathogenicity |
| 08/14/2008 | US20080194588 Modulation of pathogcnicity |
| 08/14/2008 | US20080194579 Antiinflammatory agents; chronic obstructive pulmonary disease; antihistamines; transplant rejection; antitumor agents |
| 08/14/2008 | US20080194573 3-(Heteroaryl-Oxy)-2-Alkyl-1-Aza-Bicycloalkyl Derivatives As Alpha. 7-Nachrligands For TheTreatment Of Cns Diseases |
| 08/14/2008 | US20080194501 Cyclic Bioisosters of Derivatives of a Purine System and Pharmaceutical Composition Based Thereon |
| 08/14/2008 | US20080193398 Sunscreen agents; cosmetic, dermatological, veterinary and pharmaceutical formulations that protect the skin, lips, nails and hair against UV radiation; 2,5,8-tris-(4-(2-ethylhexyloxycarbonyl)phenylamino)-1,3,4,6,7,9,9b-heptaazaphenalene |
| 08/14/2008 | CA2678193A1 Aza-bridged-ring compound |
| 08/14/2008 | CA2677995A1 Acylguanidine derivative |
| 08/14/2008 | CA2677661A1 Tricyclic compounds |
| 08/14/2008 | CA2677493A1 Pyridopyrimidinone compounds useful in treating sodium channel-mediated diseases or conditions |
| 08/14/2008 | CA2675357A1 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors |
| 08/13/2008 | EP1956020A2 1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity |
| 08/13/2008 | EP1956013A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 08/13/2008 | EP1956008A1 Organic compound, charge-transporting material, composition for charge-transporting material and organic electroluminescent device |
| 08/13/2008 | EP1954698A1 Spirocyclic compounds as hdac inhibitors |
| 08/13/2008 | EP1954697A2 Peri condensed tricyclic compounds useful as antibacterial agents |
| 08/13/2008 | EP1954290A2 Tricyclic compounds useful as inhibitors of kinases |
| 08/13/2008 | EP1954282A2 Novel process and formulations |
| 08/13/2008 | EP1954274A2 Substituted quinolones and methods of use |
| 08/13/2008 | EP1954268A2 Spirolactam bicyclic cgrp receptor antagonists |
| 08/13/2008 | EP1954136A2 Novel chemical compounds |
| 08/13/2008 | EP1954135A2 Spirolactam aryl cgrp receptor antagonists |
| 08/13/2008 | EP1954132A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 08/13/2008 | EP1753763B1 Indazole and indolone derivatives and their use as pharmaceuticals |
| 08/13/2008 | EP1664023B1 Sustituted isoquinoline derivatives and methods of use |
| 08/13/2008 | EP1541558B1 Heterocyclic compounds having hiv integrase inhibitory activity |
| 08/13/2008 | EP1539714B1 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 08/13/2008 | EP1497290B1 Process for preparing acid salts of gemifloxacin |
| 08/13/2008 | EP1495030B1 Non-steroidal progesterone receptor modulators |
| 08/13/2008 | EP1494673B1 Compounds having unique cb1 receptor binding selectivity and methods for their production and use |
| 08/13/2008 | EP1452528B1 Xanthine oxidase inhibitors |
| 08/13/2008 | EP1389098B1 Delivery of antipsychotics through an inhalation route |
| 08/13/2008 | EP1389097B1 Delivery of compounds for the treatment of parkinsons through an inhalation route |
| 08/13/2008 | EP1322309B1 High affinity small molecule c5a receptor modulators |
| 08/13/2008 | EP1020445B1 Fused pyridine derivatives |
| 08/13/2008 | CN101243099A Metal complex |
| 08/13/2008 | CN101243090A P38 MAP kinase inhibitors and methods for using the same |
| 08/13/2008 | CN101243087A 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them |
| 08/13/2008 | CN101243086A Indoli zine derivatives and their use as CRTH2 antagonists |
| 08/13/2008 | CN101243085A Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein |
| 08/13/2008 | CN101243084A Pyrrolo[2,3-B]pyridine derivatives as protein kinase inhibitors |
| 08/13/2008 | CN101243083A Naphthyridine compounds |
| 08/13/2008 | CN101243082A Hexahydro-pyrrolo-isoquinoline compounds for the treatment of CNS disorders |
| 08/13/2008 | CN101243081A Pyrido[2,3-d]pyrimidine-2,4-diamine compounds as PTP1B inhibitors |
| 08/13/2008 | CN101243080A Pyrazolo[3,4-B]pyridin-2-yl]-benzoic acid derivatives as HIV integrase inhibitors |
| 08/13/2008 | CN101243075A Novel 2,3-dihydroindole compounds |
| 08/13/2008 | CN101243072A Piperidine derivatives useful as histamine H3 antagonists |
| 08/13/2008 | CN101243050A Pyrazolone derivatives |
| 08/13/2008 | CN101242833A Pyrrolopyridine derivatives and use of same as PPAR receptor modulators |
| 08/13/2008 | CN101242832A Fused pyrazole as p38 MAP kinase inhibitors |
| 08/13/2008 | CN101239979A Heterocyclic compound capable of inversing tumor cell drug tolerance, preparation method and application thereof |
| 08/13/2008 | CN101239978A Imidazopyridines compounds |
| 08/13/2008 | CN101239977A Quadridentate-bridged ligand, its iridium complexes and iridium-rare earth ion bimetal complexes, and preparation method and application thereof |
| 08/13/2008 | CN100411230C Application of organic sulfide in positive electrode material of secondary Mg battery |
| 08/13/2008 | CN100410249C 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) Q uinolonecarboxylic acid derivative |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7411064 e.g. 4-chloro-3-(phenylsulfonyl)-1-(piperidin-4-ylmethyl)-1H-pyrazolo[4,3-b]pyridineI; antidepressant, anxiolytic agent, cognition activator; Alzheimer's disease, attention deficit disorder, schizophrenia; behavioral disorders, obsessive compulsive disorders, Parkinson's disease and epilepsy |
| 08/12/2008 | US7411053 Containing substituted or unsubstituted bipyridine, tripyridine, or phenanthroline groups, e.g., Di-[p-(2,2':6',2'')terpyridin-4'-ylbenzyl] 4,4'-azobis(4-cyanovalerate) and N,N'-di-[1,10-phenanthrolin-5-yl]-4,4'-azobis(4-cyanovalerylamide); RAFT polymerization catalysts |
| 08/12/2008 | US7410982 Heteroaryloxy/thio propanamines; improved acid stability, potency and selectivity to the dopamine transporter; improved ADME properties e.g. reduced tendency to act as a substrate and/or inhibitor the enzyme Cytochrome P450; pain; [(3R)-3-(Isoquinolin-4-yloxy)-3-phenyl-propyl]-methyl-amine hydrochloride |
| 08/12/2008 | US7410981 low toxicity; 2-[methyl[[(R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimida zol-1-yl]carbonyl]amino]ethyl acetate; superior antiulcer activity, a gastric acid secretion inhibitory action, a mucosa-protecting action, an antiHelicobacter pylori action |
| 08/12/2008 | US7410975 Small molecule toll-like receptor (TLR) antagonists |
| 08/12/2008 | US7410973 4-amino-substituted pyrimidine derivatives |
| 08/12/2008 | US7410970 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 08/12/2008 | US7410969 Antitumoral analogs of ET-743 |
| 08/12/2008 | US7410967 For combating phytopathogenic diseases on plants and harvested food crops; pyrido(2,3-B)pyrazine derivatives; volatile enough to be active in the vapour phase |
| 08/12/2008 | US7410966 Use of and some novel imidazopyridines |
| 08/12/2008 | US7410960 Metal complexes and therapeutic uses thereof |
| 08/12/2008 | CA2398111C 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 08/12/2008 | CA2322158C Arylphenyl-substituted cyclic keto-enols |
| 08/12/2008 | CA2217590C Use of imidazo[1,2-a]pyridine-3-acetamide derivatives for the therapeutic treatment of neuropsychiatric syndromes associated with dysfunction of the neural circuits of the basal ganglia |
| 08/07/2008 | WO2008094909A2 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions |
| 08/07/2008 | WO2008094574A2 Furanone compounds and methods of making and using the same |
| 08/07/2008 | WO2008094556A2 Imidazolone compounds as tgf-beta family type i receptors, alk5 and/or alk4 antagonists |
| 08/07/2008 | WO2008093825A1 Caffeine analog |
| 08/07/2008 | WO2008093065A1 L-ALANINE DERIVATIVES AS α5βL ANTAGONISTS |
| 08/07/2008 | WO2008093064A1 L-ALANINE DERIVATIVES AS α5 BETA 1 ANTAGONISTS |
| 08/07/2008 | WO2008092877A2 8-oxa-1, 4-diazaspiro [4,5] dec-3-en-1-yl and 1,4, 8-triazaspiro [4,5] dec- 3-en-1-yl acetamides as glyti transporter inhibitors in treatment of neurological and neuropsychiatric disorders |
| 08/07/2008 | WO2008092876A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 08/07/2008 | WO2008092231A1 Compounds for the prevention and treatment of cardiovascular diseases |
| 08/07/2008 | WO2008076225A3 Non-nucleoside reverse transcriptase inhibitors |
| 08/07/2008 | WO2008060487A3 Polymorphs of nicotinic intermediates |
| 08/07/2008 | WO2007138351A3 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 08/07/2008 | US20080188655 Monomer With Anti-Microbial Character, Polymer Using The Same, And Manufacturing Method Thereof |
| 08/07/2008 | US20080188536 2-thiophenecarboxylic acid-5-nitro-2-(2-thienylcarbonyl)hydrazide; antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial setting; bacterial damage or disease; Pseudomonas aeruginosa or Burkholderia cepacia |
| 08/07/2008 | US20080188535 2-thiophenecarboxylic acid-5-nitro-2-(2-thienylcarbonyl)hydrazide; antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial setting; bacterial damage or disease; Pseudomonas aeruginosa or Burkholderia cepacia |
| 08/07/2008 | US20080188515 metalloproteinases inhibitor, particular Peptide Deformylase (Pdf) inhibitor; antibiotic; e.g. 2-(6-fluoro-imidazo[1,2-a]pyridin-3-ylamino)-N-hydroxy-acetamide |
| 08/07/2008 | US20080188514 e.g. 5-(3-methoxybenzyloxy)-1H-pyrrolo[2,3-b]pyridine; protein kinases inhibitor; central nervous system disorders; Alzheimer's disease; Parkinson's disease; anticancer, antitumor agents; analgesics; cogestive heart failure; skin disorders; inflammatory bowel disorders; transplant rejection |
| 08/07/2008 | US20080188513 Good aqueous solubility and good physical and chemical stability in solid form; chemical intermediates |
| 08/07/2008 | US20080188506 6-chloro-2'-(3-chlorophenyl)-4'-(2,2-dimethylpropyl)spiro[3H-indole-3,3'-piperidine]-2,6'(1H)-dione; mdm2 antagonists; have effects in p53 mutant cells by mdm2-p53 feedback control loop; anticarcinogenic agent; |
| 08/07/2008 | US20080188500 e.g. N-[4-methyl-3-(9H-pyrimido[4,5-b]indol-7-yl)phenyl]-3-(trifluoromethyl)benzamide; Janus kinases inhibitor; anticarcinogenic agent; immune-related diseases, skin disorders, myeloid proliferative disorders |
| 08/07/2008 | US20080188491 Modulation of pathogenicity |
| 08/07/2008 | US20080188481 e.g. 1-[4-(1-Phenyl-1-(pyrazinyl)-methylene)-piperidin-1-yl]-2-(4-methoxy-7-pyrazinyl-6-azaindol-3-yl)-ethane-1,2-dione; viricides for prophylaxis of lympadenopathy associated virus; synergystic mixtures with immunomodulators |